TrialClinical and translational science2026

Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Olamkicept up to 2400 mg in Healthy Men: Phase I, Randomized, Placebo-Controlled, and Double-Blind Trial.

Stanislav Ignatenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.